118 related articles for article (PubMed ID: 7923133)
1. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.
Kihara A; Pastan I
Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).
Pai LH; Gallo MG; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2808-12. PubMed ID: 2032221
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
Kihara A; Pastan I
Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
[TBL] [Abstract][Full Text] [Related]
5. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
7. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
8. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin.
Kreitman RJ; Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):63-8. PubMed ID: 1616951
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.
Kunwar S; Pai LH; Pastan I
J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018
[TBL] [Abstract][Full Text] [Related]
10. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.
Thomas SM; Zeng Q; Epperly MW; Gooding WE; Pastan I; Wang QC; Greenberger J; Grandis JR
Clin Cancer Res; 2004 Oct; 10(20):7079-87. PubMed ID: 15501988
[TBL] [Abstract][Full Text] [Related]
12. Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules.
Siegall CB; FitzGerald DJ; Pastan I
Semin Cancer Biol; 1990 Oct; 1(5):345-50. PubMed ID: 2129426
[TBL] [Abstract][Full Text] [Related]
13. Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.
Harte MT; Gentry LE
Arch Biochem Biophys; 1995 Oct; 322(2):378-89. PubMed ID: 7574711
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo.
Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
J Ind Microbiol; 1991 Apr; 7(3):203-7. PubMed ID: 1367127
[TBL] [Abstract][Full Text] [Related]
15. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
16. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of chimeric toxins containing the epidermal growth factor-like domain of heregulins fused to PE38KDEL, a truncated recombinant form of Pseudomonas exotoxin.
Kihara A; Pastan I
Cancer Res; 1995 Jan; 55(1):71-7. PubMed ID: 7805044
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1989 Aug; 264(24):14256-61. PubMed ID: 2503515
[TBL] [Abstract][Full Text] [Related]
20. Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
Debinski W; Siegall CB; Fitzgerald D; Pastan I
Mol Cell Biol; 1991 Mar; 11(3):1751-3. PubMed ID: 1671711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
